000590 Tus-Pharmaceutical Group
- 5.06
- +0.06+1.20%
Tus-Pharmaceutical Group News
Tus-Pharmaceutical Group: Announcement on the Release of Certain Pledged Equity by One of the Company's Controlling Shareholders Jointly Acting Persons in 2024-032.
Tus-Pharmaceutical Group: An indicative announcement on the free transfer of the company's shareholders' state-owned shares and changes in shareholders' rights
Enlightenment Pharmaceutical: Announcement on the fulfillment of equity acquisition performance commitments
Enlightenment Pharmaceutical: Announcement on the completion of transfer registration of part of the controlling shareholder\'s shares being judicially auctioned
Enlightenment Pharmaceutical: 2024-002 Announcement on the acquisition of 55% of the shares of Wuhan Mingshi Pharmaceutical Co., Ltd.
Enlightenment Pharmaceutical: Progress Announcement on the Judicial Auction of Some of the Controlling Shareholders\' Shares
Enlightenment Pharmaceutical: Prompt Announcement on the Possible Judicial Auction of Some of the Controlling Shareholders\' Shares
Enlightenment Pharmaceutical: Announcement on the fulfillment of equity acquisition performance promises
Enlightenment Pharmaceutical: Announcement on the free transfer of the company's shareholders' state-owned shares to complete the transfer registration
Enlightenment Pharmaceutical: Announcement on applying for M&A loans using equity pledges from wholly-owned subsidiaries
Enlightenment Pharmaceutical: Simplified Equity Change Report - Stock Reduction (Hengyang State-owned Assets Administration Commission)
Enlightenment Pharmaceutical: Simplified Equity Change Report - Stock Increase (Hengyang Hongxiang Group)
Enlightenment Pharmaceutical: An indicative announcement on the free transfer of state-owned shares of the company's shareholders and changes in shareholders' equity
Enlightenment Pharmaceutical: Announcement on the judicial freezing of some of the company's shares held by the controlling shareholder of the company
Enlightenment Pharmaceutical: Announcement on signing a letter of intent to acquire shares
Enlighten Pharmaceutical: Enlighten Pharmaceutical's Equity Incentive Plan Self-Check Form
Enlightenment Pharmaceutical: Enlightenment Pharmaceutical's 2022 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Enlighten Pharmaceutical: Enlighten Pharmaceutical 2022 Restricted Stock Incentive Plan (Draft)
Enlighten Pharmaceutical: Enlighten Pharmaceutical's 2021 Restricted Stock Incentive Plan (Draft) Summary
Enlightenment Pharmaceutical: Announcement on the free transfer of the company's shareholders' state-owned shares to complete the transfer registration
Analysis
Price Target
No Data
